- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2010
- Public Summary Document (PSD) March 2010 PBAC Meeting - PDF
Infliximab – March 2010
Infliximab, powder for IV infusion, 100 mg, Remicade® - March 2010
Last updated
2 July 2010